Source: FinanzNachrichten

Accelerated Pharma: IPO Watch: Accelerated Pharma Gets Cold Feet

WASHINGTON (dpa-AFX) - Accelerated Pharma Inc. has formally requested SEC to withdraw its initial public offering plans.'The company requests the withdrawal of the registration statement because t...

Read full article »
Annual Revenue
$100K-5.0M
Employees
1-25
Michael Fonstein's photo - CEO of Accelerated Pharma, Inc.

CEO

Michael Fonstein

CEO Approval Rating

69/100

Read more